Assessment of balance in recruitment, enrollment, measurement, coverage of the intervention, and early postpartum hemorrhage (PPH) treatment between groups.

<p>Assessment of balance in recruitment, enrollment, measurement, coverage of the intervention, and early postpartum hemorrhage (PPH) treatment between groups.</p

Trend in PPH-1 by study arm of trial.

<p>Trend in PPH-1 by study arm of trial.</p

Secondary safety outcome measures, by group.

*<p>Defined as: clearing of infant airways, ventilation, cardiac massage.</p

Assessment of balance between the oxytocin and control groups achieved through the randomization process among enrolled women.

*<p>Includes: Bimoba/Chokosi, Fulani, Ga/Adangbe/Ewe, Sisala/Wala, Zambraba, Banda/Pantra, and other (non-specified).</p>**<p>Score based on unweighted sum of 10 household assets (electricity, radio, cooker, refrigerator, television, sewing machine, cell phone, cement floor, cement walls, non-thatch roof).</p>***<p>Reported among singleton births only.</p

Median blood loss by study arm of the trial.

<p>Median blood loss by study arm of the trial.</p

Trend in PPH-2 by study arm of trial.

<p>Trend in PPH-2 by study arm of trial.</p

Primary outcome measures, by group.

<p>Note: The intra-class correlation coefficients for PPH-1, PPH-2, and PPH-3 were 0.012, 0.051, and 0.050, respectively.</p

CONSORT flow diagram.

<p>CONSORT flow diagram.</p

The oxytocin in Uniject device.

<p><i>Source: PATH/Glenn Austin</i>.</p